Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests

BACKGROUND: Coronavirus disease (COVID-19) is interfering heavily with the screening, diagnosis and treatment of cancer patients. Better knowledge of the seroprevalence and immune response after Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in this population is important to...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dam, Peter, Huizing, Manon, Roelant, Ella, Hotterbeekx, An, De Winter, Fien H.R., Kumar-Singh, Samir, Moons, Pieter, Amajoud, Zainab, Vulsteke, Christof, Croes, Lieselot, Janssens, Annelies, Berneman, Zwi, Prenen, Hans, Meuris, Leander, Vanden Berghe, Wim, Smits, Evelien, Peeters, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914028/
https://www.ncbi.nlm.nih.gov/pubmed/33773276
http://dx.doi.org/10.1016/j.ejca.2021.02.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914028/
https://www.ncbi.nlm.nih.gov/pubmed/33773276
http://dx.doi.org/10.1016/j.ejca.2021.02.024

Ejemplares similares